Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Interest Expense Over TimeStable
Percentile Rank50
3Y CAGR-0.8%
5Y CAGR-10.8%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-0.8%/yr
vs +2.9%/yr prior
5Y CAGR
-10.8%/yr
Recent acceleration
Acceleration
-3.7pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.75M | -3.9% |
| 2024 | $11.18M | -1.3% |
| 2023 | $11.33M | +2.9% |
| 2022 | $11.01M | -44.0% |
| 2021 | $19.68M | +3.3% |
| 2020 | $19.05M | +1.2% |
| 2019 | $18.83M | +91.9% |
| 2018 | $9.81M | +121.8% |
| 2017 | $4.42M | -6.6% |
| 2016 | $4.73M | - |